This individual will work closely with Clinical Development, Clinical Operations, Biometrics, Regulatory, Research, and external partners to translate scientific insights into clinical development strategies, including patient selection, pharmacodynamic and resistance biomarkers, molecular response endpoints, indication selection, and combination strategies. Experience with relevant biomarker technologies and assays, which may include immunohistochemistry, digital pathology, flow cytometry, multiplex immunoassays, next-generation sequencing, ctDNA, RNA sequencing, and other molecular profiling approaches.